ABSTRACT. Objective. Evaluate the accuracy of this bedside method to determine hemoglobin (Hb) concentration in general surgery over a wide range of Hb values and to determine potential sources of error. Methods. Accuracy of Hb measurement using HemoCue Õ (AB Leo Diagnostics, Helsinborg, Sweden) was assessed in 140 surgical blood samples using 7 HemoCue Õ devices in comparison with a CO-Oximeter (IL 482, Instrumentation Laboratory, Lexington, MA). To analyze potential sources of error, packed red cells and fresh frozen plasma were reconstituted to randomized Hb levels of 2^18 g/dL. Results. In the surgical blood samples, the Hb concentration determined by the CO-Oximeter (HbCOOX) ranged from 5.1 to 16.7 g/dL and the Hb concentration measured by HemoCue Õ (HbHC) from 4.7 to 16.0 g/dL. Bias (HbCOOX^HbHC) between HbCOOX and HbHC was 0.6 AE 0.6 g/dL (mean AE SD) or 5.4 AE 5.0% (p0 .001). Also in the reconstituted blood, the bias between HbCOOX and HbHC was signi¢cant (0.2 AE 0.3 g/dL or 2.1 AE 3.2%; p`0.001). 
INTRODUCTION
Avoiding allogeneic blood transfusions is an important issue in the perioperative care of surgical patients [1, 2] . Low hemoglobin values thus are frequently tolerated. This mandates a fast and reliable method of hemoglobin determination. In many centers, however, blood samples have to be transferred to a laboratory area remote of the operating theater for hemoglobin determination. Delays in analyzing hemoglobin levels might contribute to a prolonged exposure of a patient to a very low hemoglobin level with potential untoward consequences. HemoCue Õ (AB Leo Diagnostics, Helsinborg, Sweden) represents a bedside hemoglobin measurement device with acceptable accuracy in cardiac surgery [3, 4] as well as in fetal [5, 6] , pediatric [7, 8] , and outpatient units [9, 10] .
The purpose of this study was twofold: First, to evaluate the accuracy of this bedside hemoglobin measurement technique over a wide range of Hb values in general surgery patients during hemodilution, surgical blood loss and red blood cell transfusion and second, to analyze potential sources of error. Analyzing potential sources of error is important because in most studies in which the overall bias between HemoCue Õ and the reference method hemoglobin concentrations was considered acceptable, a signi¢cant variability was observed between the HemoCue Õ and the reference hemoglobin concentrations [4, 7^9] . To analyze potential sources of error, heparinized packed red cells and fresh frozen plasma were reconstituted to randomized Hb levels of 2^18 g/dL for speci¢c comparisons between HemoCue Õ and CO-Oximeter hemoglobin measurements. There were no exclusion criteria for this study. Õ device, all 20 measurements were performed before the next device was tested. The HemoCue Õ device uses a modi¢ed azide methemoglobin reaction [6^8] for hemoglobin quanti¢cation. Following red-cell lysis, sodium nitrate converts hemoglobin to methemoglobin, which is then combined with azide. The adsorbance of the azide methemoglobin is then photometrically measured at 565 nm and 880 nm. The CO-Oximeter used in the present study is a micro-computer controlled system which measures the Hb concentration with monochromatic light at four speci¢c wavelengths (535 nm, 585 nm, 595 nm, 627 nm) [11^13]. All hemoglobin measurements were performed immediately after sampling using a single 2-ml syringe of blood that was mixed continuously. All measurements were performed by a single operator.
MATERIALS AND METHODS
To analyze potential sources of error, heparinized packed red cells and fresh frozen plasma were reconstituted to randomized Hb levels of 2^18 g/dL (in steps of 2 g/dL). At each hemoglobin level 10 microcuvettes were loaded and the hemoglobin concentration was determined by all 7 HemoCue Õ devices in randomized order. Simultaneously, the hemoglobin concentration was measured 10 times with the CO-Oximeter. All microcuvettes were measured with all HemoCue Õ devices resulting in 70 measurements at each Hb level. All microcuvettes were inspected after being loaded to ensure there were no bubbles in the light path [9, 10] . By using new microcuvettes we prevented humidity to interact with the dried-reagent-coated microcuvettes [14] . In both series, the HemoCue Õ devices used were checked with the device-speci¢c, calibrated mircocuvette before and after use.
Data (mean AE SD) of the surgical blood samples as well as of the reconstituted blood were compared using bias analysis. A potential learning e¡ect was sought in the surgical blood samples by analyzing bias and variability between HemoCue Õ and CO-Oximeter hemoglobin concentrations in relation to the sequence in which these measurements were performed using analysis of variance (ANOVA) with post-hoc BonferroniDunn correction.
The di¡erence between HemoCue Õ and CO-Oximeter hemoglobin concentrations of the reconstituted blood was further analyzed by variance components analysis and Wilcoxon's signed rank test. Thereby, a three way analysis of variance with the factors Hb level, HemoCue Õ device and microcuvette nested in Hb level was performed. Variability of the methods was compared in the reconstituted blood samples using absolute residuals for each Hb level (2 to 18 g/dL).
RESULTS

All HemoCue
Õ devices always measured the hemoglobin concentration of the calibrated microcuvette within AE 0.1 g/dL.
In the surgical blood samples, the Hb concentration determined by the CO-Oximeter (HbCOOX) ranged from 5.1 to 16.7 g/dL and the Hb concentration measured by HemoCue Õ (HbHC) from 4.7 to 16.0 g/dL. Bias (HbCOOX^HbHC) between HbCOOX and HbHC was 0.6 AE 0.6 g/dL ( Figure 1A ) or 5.4 AE 5.0% ( Figure 1B) (p`0.001, each) . The di¡erence between the two measurement techniques (HbCOOX^HbHC) exceeded 1.0 g/dL in 25 of 140 samples (17.9%) but never fell below À1 g/dL. In 121 of 140 paired measurements (86.4%), the HbHC was within AE10% of HbCOOX. A signi¢cant (p`0.001) learning e¡ect was found such that bias and variability between HemoCue Õ and CO-Oximeter hemoglobin concentrations were higher in the ¢rst 40 measurements compared with the subsequent 100 comparative measurements. However, no further improvement was found in these subsequent 100 measurements (Figure 2) . Also in the reconstituted blood, the bias between HbCOOX and HbHC was signi¢cant (0.2 AE 0.3 g/dL ( Figure 3A ) or 2.1 AE 3.2% ( Figure 3B) ; p`0.001). The di¡erence between the two measurement techniques (HbCOOX^HbHC) exceeded 1.0 g/dL in 6 of 630 samples (0.95%) but never fell below À1 g/dL. All HbHC measurements were within AE10% of HbCOOX. Variability of hemoglobin measurement using HemoCue Õ was 8^10 times higher compared with hemoglobin determination by the CO-Oximeter (p`0.001).
In the reconstituted blood, we also computed variance components for the di¡erence between HbHC and HbCOOX using a three way ANOVA with the factors Hb level, device and microcuvette nested in Hb level. All e¡ects were highly signi¢cant (p`0.0001). The microcuvette was found by far the most important factor explaining 68% of the variability between HbCOOX and HbHC followed by Hb level (13%) and HemoCue Õ device (5%).
DISCUSSION
HemoCue Õ underestimates the Hb concentration as determined by a CO-Oximeter by 2^5% and exhibits a signi¢cantly higher variability. The microcuvette is by far the most important factor explaining the di¡erence between HbCOOX and HbHC. Thus, loading multiple microcuvettes and averaging the results may increase accuracy and reliability of Hb measurement using HemoCue Õ . The IL-482 CO-Oximeter used in the present study as the reference method is a micro-computer controlled system which measures the Hb concentration with [12] and a nearly ideal linear regression equation of 0.99x + 0.7 (r2 = 0.99) [13] . However, only limited information is available on the variability of the IL-482 CO-Oximeter. In the present study a minimal variability was documented when the reconstituted blood with hemoglobin concentrations ranging from 2 to 18 g/dL was measured 10 times at each hemoglobin concentration with the IL-482 COOximeter and standard deviations of 0.0 g/dL (8 of 9 hemoglobin concentrations) and 0.1 g/dL (1 of 9 hemoglobin concentration) were found. The variability between the HemoCue Õ and IL-482 CO-Oximeter hemoglobin concentration observed in the present study thus is caused nearly exclusively by the variability of the HemoCue Õ methodology. The HemoCue Õ is a convenient bedside device using a modi¢ed azide methemoglobin reaction [6^8] for hemoglobin quanti¢cation. Following red-cell lysis, sodium nitrate converts hemoglobin to methemoglobin, which is then combined with azide. The adsorbance of the azide methemoglobin is photometrically measured at 565 nm and 880 nm within 15^45 seconds. The system uses small dried-reagent-coated disposable microcuvettes in which 10 mL of blood is drawn by capillary action. Although handling of the HemoCue Õ device appears trivial, a distinct learning e¡ect was found in the present study ( Figure 2 ). However, even after the initial learning e¡ect, a 8^10 times greater variability of the HemoCue Õ methodology remains as compared with the IL-482 CO-Oximeter as documented in the analysis of the reconstituted blood which was performed after the measurements in the surgical blood samples.
Despite avoiding preventable errors in the handling of the HemoCue Õ , such as air bubbles in the light path [9, 10] or using microcuvettes not stored in a dry environment [14] , we found a systematic underestimation of the Hb concentration by HemoCue Õ of 2.1 AE 3.2% in reconstituted blood and 5.4 AE 5.0% in surgical blood samples. This underestimation is in keeping with previous reports [3^10]. For most clinical applications an average underestimation of the Hb concentration of approximately 5% appears acceptable. However, the variability of the HemoCue Õ device was 8^10 times higher compared with the CO-Oximeter resulting in a di¡erence of more than 10% in nearly one of six clinical measurements. Should this not be acceptable, loading multiple microcuvettes and averaging the results may decrease this discrepancy since 68% of the di¡erence between HemoCue Õ and CO-Oximeter readings were found to be due to the microcuvette.
Due to the systematic underestimation, the true Hb concentration is likely to be similar or higher than the Hb concentration displayed by the HemoCue Õ device. In clinical situations in which a 10% accuracy is acceptable, the HemoCue Õ device thus may be used as a quick bedside screening method for Hb concentration measurement before sending a blood sample to a central laboratory in order to avoid prolonged exposure of a patient to a very low hemoglobin level with potential untoward consequences. 
